Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Inference Corporation--Growing 100% and still inexpensive -- Ignore unavailable to you. Want to Upgrade?

To: Dan Berger who wrote (1126)	2/2/1999 12:48:00 AM
From: zTrader_77	Read Replies (1) \| Respond to of 1246

There are some interesting comments in this article that I believe could impact INFR in a positive way. Remedy's (RMDY) chief executive, Larry Garlick, said the company's goal is to develop software that's ready to use in less than three months. Remedy plans to target mid-tier customers, a category Garlick defined as companies having $10 million to $250 million in revenue. He said the Web is "key to winning the customer market." Source of article: cbs.marketwatch.com Kirby